Familial liability to complications after BCG vaccination

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 8, 1997, Pages 899-902

  Banac, S ^a   Franulovic J ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Adverse reaction; Bacille Calmette Guerin; Congenital immunodeficiency; Genetic susceptibility; Vaccination

Indexed keywords

BCG VACCINE;

ARTICLE; BCG VACCINATION; CASE REPORT; DISEASE COURSE; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE DEFICIENCY; INFANT; INFECTION PREVENTION; INFECTION SENSITIVITY; MALE; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 0030759681     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb08620.x     Document Type: Article

References (17)

1. Sorensen RU, Moore C. Immunology in the pediatrician's office. Pediatr Clin North Am 1994; 41: 691-714
2. Lotte A, Wasz-Hockert O, Poisson N et al. Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull Int Union Tuberc Lung Dis 1988; 63: 47-59
3. Stead WW. Genetics and resistance to tuberculosis. Ann Intern Med 1942; 116: 937-41
4. Gonzales B, Moreno S, Burdach R, Valenzuela MT, Henriquez A, Ramos MI, Sorensen RU. Clinical presentation of Bacillus Calmette-Guerin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J 1989; 8: 201-6
5. Romanus V, Fasth A, Tordai P, Wiholm BE. Adverse reactions in healthy and immunocompromised children under six years of age vaccinated with the Danish BCG vaccine, strain Copenhagen 1331: implications for the vaccination policy in Sweden. Acta Paediatr 1993; 82: 1043-52
6. Rosen FS, Cooper MD, Wedgwood RJP. The primary immunodeficiencies. N Engl J Med 1984; 311: 300-10
7. Berthet F, Le Deist F, Duliege AM, Griscelli C, Fischer A. Clinical consequences and treatment of primary immunodeficiency syndromes characterised by functional T and B lymphocyte anomalies (combined immune deficiency). Pediatrics 1994; 93: 265-70
8. Šićevié S. Generalized BCG tuberculosis with fatal course in two sisters. Acta Paediat Scand 1972; 61: 178-84
9. Passwell J, Katz D, Frank Y, Spirer Z, Cohen BE, Ziprkowski M. Fatal disseminated BCG infection (an investigation of the immunodeficiency). Am J Dis Child 1976; 130: 433-6
10. Karup Pedersen F, Engbaek HC, Hertz H, Vergmann B. Fatal BCG infection in an immunocompetent girl. Acta Paediatr Scand 1978; 67: 519-23
11. Alarcon B, Regueiro JR, Arnaiz-Villena A, Terhorst C. Familial defect in the surface expression of the T-cell receptor-CD3 complex. N Engl J Med 1988; 319: 1203-7
12. Chatila T, Wong R, Young M, Miller R, Terhorst C, Geba RS. An immunodeficiency characterized by defective signal transduction in T lymphocytes. N Engl J Med 1989; 320: 696-702
13. Weinberg K, Parkman R. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. N Engl J Med 1990; 322: 1718-23
14. Bellanti JA, Kadlee JV, Evscobar-Gutierrez A. Cytokines and the immune response. Pediatr Clin North Am 1994; 41: 597-621
15. Levin M, Newport MJ, D'Souza S, Kalabalikis P, Brown IN, Lenicker HM et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995; 345: 79-83
16. Vidal SM, Malo D, Vogan K, Skamene E, Gros Ph. Natural resistance to infection with intracellular parasites: isolation of a candidate for BCG. Cell 1993; 73: 469-85
17. Newport M, Levin M, Blackwell J, Shaw M-A, Williamson R, Huxley C. Evidence for exclusion of a mutation in NRAMP as the cause of familial disseminated atypical mycobacterial infection in a Maltese kindred. J Med Genet 1995; 32: 904-6